YOGISH C contact KUDVA

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people
    Chinmay Manohar
    Center for Clinical Investigation, Case Medical School, Case Western Reserve University, Cleveland, Ohio, USA
    Diabetes Care 35:2493-9. 2012
  2. pmc Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation
    Tayaramma Thatava
    Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Stem Cell Res Ther 2:48. 2011
  3. pmc Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells
    Seiga Ohmine
    Department of Molecular Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Stem Cell Res Ther 2:46. 2011
  4. doi request reprint Patient-centred treatments for type 2 diabetes
    Yogish C Kudva
    Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, MN 55905, USA
    Lancet 371:1047-8. 2008
  5. ncbi request reprint "Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes
    Yogish C Kudva
    Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota 55905 0001, USA
    Diabetes Care 25:121-6. 2002
  6. ncbi request reprint Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes
    Yogish C Kudva
    Division of Endocrinology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Diabetes Care 28:10-4. 2005
  7. ncbi request reprint Mastopathy and diabetes
    Yogish C Kudva
    Division of Endocrinology and Metabolism, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
    Curr Diab Rep 3:56-9. 2003
  8. ncbi request reprint Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules
    Govindarajan Rajagopalan
    Department of Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Diabetes 52:342-7. 2003
  9. ncbi request reprint Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin
    Yogish C Kudva
    Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    Endocr Pract 13:244-50. 2007
  10. ncbi request reprint Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes
    Govindarajan Rajagopalan
    Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Autoimmunity 40:489-96. 2007

Research Grants

  1. Integrated approaches to close the loop in type 1 diabetes
    YOGISH C contact KUDVA; Fiscal Year: 2010

Collaborators

Detail Information

Publications30

  1. pmc The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people
    Chinmay Manohar
    Center for Clinical Investigation, Case Medical School, Case Western Reserve University, Cleveland, Ohio, USA
    Diabetes Care 35:2493-9. 2012
    ..Quantifying the effects of PA on glycemic variability would improve artificial endocrine pancreas (AEP) algorithms...
  2. pmc Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation
    Tayaramma Thatava
    Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Stem Cell Res Ther 2:48. 2011
    ..Induced pluripotent stem (iPS) cell technology, which allows derivation of patient-specific pluripotent stem cells, could provide a possible alternative modality for kidney replacement therapy for patients with ESRD...
  3. pmc Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells
    Seiga Ohmine
    Department of Molecular Medicine, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Stem Cell Res Ther 2:46. 2011
    ..One of the key issues for clinical-grade iPSC derivation is the accessibility of donor cells used for reprogramming...
  4. doi request reprint Patient-centred treatments for type 2 diabetes
    Yogish C Kudva
    Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, MN 55905, USA
    Lancet 371:1047-8. 2008
  5. ncbi request reprint "Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes
    Yogish C Kudva
    Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota 55905 0001, USA
    Diabetes Care 25:121-6. 2002
    ..To demonstrate the strong association of diabetic mastopathy or sclerosing lymphocytic lobulitis with type 1 diabetes mellitus by studying appropriate control groups and to describe risk factors and natural history of the disorder...
  6. ncbi request reprint Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes
    Yogish C Kudva
    Division of Endocrinology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Diabetes Care 28:10-4. 2005
    ..We conducted a randomized crossover design clinical trial to compare glargine with ultralente insulin as a basal insulin in type 1 diabetes...
  7. ncbi request reprint Mastopathy and diabetes
    Yogish C Kudva
    Division of Endocrinology and Metabolism, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
    Curr Diab Rep 3:56-9. 2003
    ..It may be associated with retinopathy and neuropathy, but more research is needed to verify this association. The etiopathogenesis is unknown and the disorder does not seem to predispose to breast carcinoma or lymphoma...
  8. ncbi request reprint Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules
    Govindarajan Rajagopalan
    Department of Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Diabetes 52:342-7. 2003
    ..We also show for the first time that diabetes in NOD.RIP-TNF mice can occur independent of inheritance of NOD-derived idd1...
  9. ncbi request reprint Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin
    Yogish C Kudva
    Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    Endocr Pract 13:244-50. 2007
    ..To evaluate glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes receiving multiple daily insulin injections during glargine and Ultralente use as basal insulin in a clinical trial...
  10. ncbi request reprint Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes
    Govindarajan Rajagopalan
    Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Autoimmunity 40:489-96. 2007
    ..Thus, the relative roles of CD4+ or CD8+T cells in the pathogenesis of T1D are possibly determined by the local inflammatory stimuli...
  11. ncbi request reprint IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice
    Govindarajan Rajagopalan
    Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Cytokine 34:85-95. 2006
    ..This was accompanied by a heightened systemic inflammatory cytokine response and mortality following in vivo challenge with a toll-like receptor 9 agonist, CpG-containing DNA...
  12. doi request reprint Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system
    Steven A Smith
    Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 83:747-57. 2008
    ..To assess the effect of a specialist telemedicine intervention for improving diabetes care using the chronic care model (CCM)...
  13. doi request reprint Long-term benefits of pancreas transplantation
    Patrick G Dean
    Division of Transplant Surgery, Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Curr Opin Organ Transplant 13:85-90. 2008
    ..With more recipients enjoying normoglycemia for longer periods of time, the opportunity to study more closely the effects of pancreas transplantation has arisen. This review will focus on these long-term benefits...
  14. ncbi request reprint Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans
    Govindarajan Rajagopalan
    Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA
    Int Immunol 15:1035-44. 2003
    ..In conclusion, this study confirmed the diabetogenic potential of HLA-DQ8 and established the role of HLA-DR3 in the pathogenesis of T1D...
  15. ncbi request reprint Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II
    Yogish C Kudva
    Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, MN, USA
    Hum Immunol 63:987-99. 2002
    ..In conclusion, transgenic expression of HLA-DR3 and -DQ8 associated with predisposition to type 1 diabetes alone is not sufficient to induce spontaneous diabetes in NOD mice lacking endogenous class II molecules...
  16. doi request reprint Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections
    Mitra M Fatourechi
    Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 94:729-40. 2009
    ..Hypoglycemia limits the efficacy of intensive insulin therapy. The extent to which continuous insulin infusion (CSII) overcomes this limitation is unclear...
  17. ncbi request reprint Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis
    Victor M Montori
    Division of Endocrinology, Diabetes, Metabolism, Nutrition, and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Diabetes Care 27:1088-94. 2004
    ..To determine the efficacy of telecare (modem transmission of glucometer data and clinician feedback) to support intensive insulin therapy in patients with type 1 diabetes and inadequate glycemic control...
  18. doi request reprint Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis?
    Mae Sheikh-Ali
    Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, Rochester, Minnesota 55905, USA
    Diabetes Care 31:643-7. 2008
    ..The present study was undertaken to determine whether quantitative measurement of a ketone body anion could be used to diagnose DKA...
  19. ncbi request reprint Melanin concentrating hormone is a novel regulator of islet function and growth
    Pavlos Pissios
    Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
    Diabetes 56:311-9. 2007
    ..Together, these data provide novel evidence for an autocrine role for MCH in the regulation of beta-cell mass dynamics and in islet secretory function and suggest that MCH is part of a hypothalamic-islet (pancreatic) axis...
  20. ncbi request reprint Insulin sensitizers
    Farhad Zangeneh
    Division of Endocrinology, Diabetes, Metabolism, Nutrition and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 78:471-9. 2003
    ..We discuss safety issues of these agents, their potential use in preventing onset and progression of diabetes, and their use in other related metabolic conditions such as polycystic ovary syndrome...
  21. ncbi request reprint Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans
    Govindarajan Rajagopalan
    Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Autoimmunity 40:169-79. 2007
    ....
  22. doi request reprint Immunotherapeutic agents in type 1 diabetes: a systematic review and meta-analysis of randomized trials
    Gunjan Y Gandhi
    Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Endocrinol (Oxf) 69:244-52. 2008
    ..We conducted a systematic review and meta-analysis to determine the efficacy of nonantigen-based immunotherapeutic approaches for preservation of beta-cell function in patients with type 1 diabetes...
  23. pmc Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features
    Farid H Mahmud
    From the Division of Pediatric Endocrinology and Metabolism, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Mayo Clin Proc 80:1429-34. 2005
    ....
  24. ncbi request reprint Posttransplantation diabetes: a systematic review of the literature
    Victor M Montori
    Division of Endocrinology, Diabetes, Metabolism, Nutrition, and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Diabetes Care 25:583-92. 2002
    ..To systematically review the incidence of posttransplantation diabetes (PTD), risk factors for its development, prognostic implications, and optimal management...
  25. doi request reprint Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation
    Nassir Rostambeigi
    Division of Endocrinology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA
    Transplantation 89:1126-33. 2010
    ..Bladder drainage increases infection risk and low ALC partially predicts episodes. Limitations include retrospective design, unequal composition of PT groups, and lack of data between kidney and PT for PAK...
  26. ncbi request reprint Pancreas-after-kidney transplantation: an increasingly attractive alternative to simultaneous pancreas-kidney transplantation
    Timothy S Larson
    Department of Internal Medicine, Division of Nephrology, Mayo Clinic, Rochester, MN 559805, USA
    Transplantation 77:838-43. 2004
    ..The purpose of this study was to compare PAK transplantation to SPK transplantation in the Thymoglobulin induction era...
  27. ncbi request reprint Potentially important contribution of dextrose used as diluent to hyperglycemia in hospitalized patients
    Bryan J Krajicek
    Diabetes Care 28:981-2. 2005
  28. ncbi request reprint Strategies to improve outcomes after renal transplantation
    Victor M Montori
    N Engl J Med 346:2089-92; author reply 2089-92. 2002
  29. ncbi request reprint Caring advice. Interview by Carol Trueman
    Yogish C Kudva
    Caring 24:37-41. 2005
  30. ncbi request reprint Residual dysphasia after severe hypoglycemia in a patient with immune-mediated primary adrenal insufficiency and type 1 diabetes mellitus: case report and systematic review of the literature
    Fatima Ajaz
    Department of Internal Medicine, University of Connecticut, Farmington, Connecticut, USA
    Endocr Pract 13:384-8. 2007
    ....

Research Grants2

  1. Integrated approaches to close the loop in type 1 diabetes
    YOGISH C contact KUDVA; Fiscal Year: 2010
    ..We believe that information obtained from our research will result in the development of a first generation endocrine artificial pancreas. ..